Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion

Brain Research

Volumn 1281, Issue , 2009, Pages 84-90

  Tan, Zhenjun ^a   Li, Xinlan ^a   Kelly, Kimberly A ^a   Rosen, Charles L ^a   Huber, Jason D ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cerebral ischemia; Cortex; Edema; Striatum; Stroke; Tissue plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; CORPUS STRIATUM; EDEMA; FEMALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; EDEMA; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR;

ANIMALIA; RATTUS;

EID: 67649401663     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.042     Document Type: Article

References (42)

1. Akkawi S., Nassar T., Tarshis M., Cines D.B., and Higazi A.A. LRP and alphavbeta3 mediate tPA activation of smooth muscle cells. Am. J. Physiol., Heart Circ. Physiol. 291 (2006) H1351-H1359
2. Armstead W.M., Cines D.B., and Higazie A.A. Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injury. Brain Res. Dev. Brain Res. 156 (2005) 139-146
3. Armstead W.M., Nassar T., Akkawi S., Smith D.H., Chen X.H., Cines D.B., and Higazi A.A. Neutralizing the neurotoxic effects of exogenous and endogenous tPA. Nat. Neurosci. 9 (2006) 1150-1155
4. Benchenane K., Berezowski V., Ali C., Fernandez-Monreal M., Lopez-Atalaya J.P., Brillault J., Chuquet J., Nouvelot A., MacKenzie E.T., Bu G., Cecchelli R., Touzani O., and Vivien D. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111 (2005) 2241-2249
5. Bertorelli R., Adami M., Di Santo E., and Ghezzi P. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci. Lett. 246 (1998) 41-44
6. D'Agostino R.B., Wolf P.A., Belanger A.J., and Kannel W.B. Stroke risk profile: adjustment for antihypertensive medication. The Framington Study. Stroke 25 (1994) 40-43
7. Dawson T.M., and Dawson V.L. Taming the clot-buster tPA. Nat. Med. 12 (2006) 993-994
8. DiNapoli V.A., Rosen C.L., Nagamine T., and Crocco T. Selective MCA occlusion: a precise embolic stroke model. J. Neurosci. Methods 154 (2006) 233-238
9. DiNapoli V.A., Huber J.D., Houser K., Li X., and Rosen C.L. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol. Aging 29 (2008) 753-764
10. Funato H., Kawano H., Akada Y., Katsuki Y., Sato M., and Uemura A. Effects of a calcium antagonist, lacidipine, on experimental focal cerebral ischemia in rats. Jpn. J. Pharmacol. 75 (1997) 415-423
11. Gibson G.E., and Peterson C. Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J. Neurochem. 37 (1981) 978-984
12. Goto H., Fujisawa H., Oka F., Nomura S., Kajiwara K., Kato S., Fuji M., Maekawa T., and Suzuki M. Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain. J. Neurotrauma. 24 (2007) 745-752
13. Guzmán-Godínez G., and Schliebs R. Effect of kainic acid administration to prepubescent rats on cholinergic markers in selected brain regions of adult rats. Neurochem. Int. 21 (1992) 447-453
14. Imai H., Masayasu H., Dewar D., Graham D.I., and Macrae I.M. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32 (2001) 2149-2154
15. Kidwell C.S., Saver J.L., Carneado J., Sayre J., Starkman S., Duckwiler G., Gobin Y.P., Jahan R., Vespa P., Villablanca J.P., Liebeskind D.S., and Vinuela F. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 333 (2008) 717-724
16. Knox C.A., Yates R.D., Chen I., and Klara P.M. Effects of aging on the structural and permeability characteristics of cerebrovasculature in normotensive and hypertensive strains of rats. Acta Neuropathol. 51 (1980) 1-13
17. Lazzaro A., Seren M.S., Koga T., Zanoni R., Schiavo N., and Manev H. GM1 reduces infarct volume after focal cerebral ischemia. Exp. Neurol. 125 (1994) 278-285
18. Liu L.S., Zhao Y., Lei Y.P., Wang W., Zhang X.E., and Jin L. Calcium antagonists in prevention of hypertension and stroke in stroke-prone spontaneously hypertensive rats. Chin. Med. J. 102 (1989) 106-113
19. Maier C.M., Ahern K., Cheng M.L., Lee J.E., Yenari M.A., and Steinberg G.K. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke 29 (1998) 2171-2180
20. Miquel J., Binnard R., and Fleming J.E. Role of metabolic rate and DNA-repair in Drosophila aging: implications for the mitochondrial mutation theory of aging. Exp. Gerontol. 18 (1983) 167-171
21. Nickell J., Salvatore M.F., Pomerleau F., Apparsundaram S., and Gerhardt G.A. Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol. Aging 28 (2007) 1737-1748
22. O'Rourke M.F. Arterial aging: pathophysiological principles. Vasc. Med. 12 (2007) 329-341
23. Petcu E.B., Sfredel V., Platt D., Herndon J.G., Kessler C., and Popa-Wagner A. Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review. Gerontology 54 (2008) 6-17
24. Popa-Wagner A., Dinca I., Yalikun S., Walker L., Kroemer H., and Kessler C. Accelerated delimitation of the infarct zone by capillary-derived nestin-positive cells in aged rats. Curr. Neurovasc. Res. 3 (2006) 3-13
25. Popa-Wagner A., Badan I., Walker L., Groppa S., Patrana N., and Kessler C. Accelerated infarct development cytogenesis and apoptosis following transient cerebral ischemia in aged rats. Acta Neuropathol. 113 (2007) 277-293
26. Ridenour T.R., Warner D.S., Todd M.M., and Baker M.T. Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. Brain Res. 565 (1991) 116-122
27. Rosen C.L., DiNapoli V.A., Nagamine T., and Crocco T. Influence of age on stroke outcome following transient focal ischemia. J. Neurosurg. 103 (2005) 687-694
28. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Reulen H.J. Monotherapy with dexamethasone or trilizad - but not a combination of both improves outcome after transient focal cerebral ischemia in rats. Exp. Brain Res. 122 (1998) 121-127
29. Schroeter M.L., Cutini S., Wahl M.M., Scheid R., and Yves von Cramon D. Neurovascular coupling is impaired in cerebral microangiopathy - an event-related Stroop study. NeuroImage 34 (2007) 26-34
30. Seyfried D., Han Y., Lu D., Chen J., Bydon A., and Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J. Neurosurg. 101 (2004) 104-107
31. Shuaib A., Ijaz S., Mazagri R., and Senthilsevlvan A. CGS-19755 is neuroprotective during repetitive ischemia: this effect is significantly enhanced when combined with hypothermia. Neuroscience 56 (1993) 915-920
32. Simon R., and Shiraishi K. N-methyl-d-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann. Neurol. 27 (1990) 606-611
33. Snape M.F., Baldwin H.A., Cross A.J., and Green A.R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience 53 (1993) 837-844
34. Stoll G., Jander S., and Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56 (1998) 149-171
35. Sugimori H., Speller H., and Finkelstein S.P. Intravenous basic fibroblast factor produces a persistent reduction in infarct volume in a permanent focal ischemia in rats. Neurosci. Lett. 300 (2001) 13-16
36. Tsirka S.E., Gualandris A., Amaral D.G., and Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377 (1995) 340-344
37. Turski L., Huth A., Sheardown M., McDonald F., Neuhaus R., Schneider H.H., Dirnagl U., Wiegand F., Jacobsen P., and Ottow E. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10960-10965
38. Yang Y., Shuaib A., and Li Q. Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method. J. Neurosci. Methods 84 (1998) 9-16
39. Yanming W.F., Tsirka S.E., Strickland S., Steig P.E., Soriano S.G., and Lipton S.A. Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4 (1998) 228-231
40. Zaletel M., Struci M., Pretnar-Oblak J., and Zvan B. Age-related changes in the relationship between visual evoked potentials and visually evoked cerebral blood flow velocity responses. Funct. Neurology 20 (2005) 115-120
41. Zhang P., Liu Y., Li J., Chen X., Tian Y., Sun J., and Liu J. Effects of ketamine and midazolam combination anesthesia on focal cerebral ischemia injury in rats. Sichuan da xue bao 36 (2005) 351-354
42. Zhao H., Mayhan W.G., and Sun H. A modified suture technique produces consistent cerebral infarction in rats. Brain Res. 1246 (2008) 158-166